Global health

Last updated

The World Health Organization in Geneva, Switzerland World Health Organisation building from south.jpg
The World Health Organization in Geneva, Switzerland

Global health is the health of the populations in the worldwide context; [1] it has been defined as "the area of study, research, and practice that places a priority on improving health and achieving equity in health for all people worldwide". [2] Problems that transcend national borders or have a global political and economic impact are often emphasized. [3] Thus, global health is about worldwide health improvement (including mental health), reduction of disparities, and protection against global threats that disregard national borders, [4] [5] including the most common causes of human death and years of life lost from a global perspective.

Contents

Global health is not to be confused with international health, which is defined as the branch of public health focusing on developing nations and foreign aid efforts by industrialized countries. [6]

One way that global health can be measured is through the prevalence of various global diseases in the world and their threat to decrease life expectancy in the present day. Estimates suggest that in a pre-modern, poor world, life expectancy was around 30 years in all regions of the world (mainly due to high infant mortality). [7] Another holistic perspective called One Health can be used to address global health challenges and to improve global health security. [8] [9] [10]

The predominant agency associated with global health (and international health) is the World Health Organization (WHO). Other important agencies impacting global health include UNICEF and World Food Programme (WFP). The United Nations system has also played a part in cross-sectoral actions to address global health and its underlying socioeconomic determinants with the declaration of the Millennium Development Goals [11] and the more recent Sustainable Development Goals.

Definition

Open Global Health at OpenCon 2015 Open Global Health at OpenCon 2015.jpg
Open Global Health at OpenCon 2015

Global health employs several perspectives that focus on the determinants and distribution of health in international contexts.

Both individuals and organizations working in the domain of global health often face many questions regarding ethical and human rights. Critical examination of the various causes and justifications of health inequities is necessary for the success of proposed solutions. Such issues are discussed at the bi-annual Global Summits of National Ethics/Bioethics Councils. [17]

History

Life expectancy by world region, from 1770 to 2018 Life expectancy by world region, from 1770 to 2018.svg
Life expectancy by world region, from 1770 to 2018

Global health as a discipline is widely acknwoledged to be of imperial origin and the need for its decolonisation has been widely recognised. [18] [19] [20] The global health ecosystem has also been criticised as having a feudal structure, acting for a small group of institutions and individuals based in high-income countries which acts similar to an imperial "Crown". [21] Some key leaders of the decolonising global health movement are Seye Abimbola and Madhukar Pai.

Important steps were taken towards global co-operation in health with the formation of the United Nations (UN) and the World Bank Group in 1945, after World War II. In 1948, the member states of the newly formed United Nations gathered to create the World Health Organization. A cholera epidemic that took 20,000 lives in Egypt in 1947 and 1948 helped spur the international community to action. [22] The WHO published its Model List of Essential Medicines, and the 1978 Alma Ata declaration underlined the importance of primary health care. [23]

At a United Nations Summit in 2000, member nations declared eight Millennium Development Goals (MDGs), [24] which reflected the major challenges facing human development globally, to be achieved by 2015. [25] The declaration was matched by unprecedented global investment by donor and recipient countries. According to the UN, these MDGs provided an important framework for development and significant progress has been made in a number of areas. [26] However, progress has been uneven and some of the MDGs were not fully realized including maternal, newborn and child health and reproductive health. [26] Building on the MDGs, a new Sustainable Development Agenda with 17 Sustainable Development Goals (SDGs) has been established for the years 2016–2030. [26] The first goal being an ambitious and historic pledge to end poverty. [27] On 25 September 2015, the 193 countries of the UN General Assembly adopted the 2030 Development Agenda titled Transforming our world: the 2030 Agenda for Sustainable Development. [27]

Several major initiatives began in the 2000s, including the vaccine alliance GAVI in 2000, The Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002, U.S. President's Emergency Plan for AIDS Relief in 2003, and the U.S. President's Malaria Initiative in 2005. In this decade and as part of the Monterrey Consensus (which didn't pursue goals as aggressively as many activists had urged), [28] an increasing emphasis was put on measuring improvement in health outcomes, rather than merely the amount of money spent. [29]

In 2015 a book titled "To Save Humanity" was published, with nearly 100 essays regarding today's most pressing global health issues. [30] The essays were authored by global figures in politics, science, and advocacy ranging from Bill Clinton to Peter Piot, and addressed a wide range of issues including vaccinations, antimicrobial resistance, health coverage, tobacco use, research methodology, climate change, equity, access to medicine, and media coverage of health research.

Measures

Measures of global health include disability-adjusted life year (DALY), quality-adjusted life years (QALYs), and mortality rate. [31]

Disability-adjusted life years

Disability-adjusted life years per 100,000 people in 2004:
.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}
No data
Less than 9,250
9,250-16,000
16,000-22,750
22,750-29,500
29,500-36,250
36,250-43,000
43,000-49,750
49,750-56,500
56,500-63,250
63,250-70,000
70,000-80,000
Over 80000 All Causes world map - DALY - WHO2004.svg
Disability-adjusted life years per 100,000 people in 2004:
  No data
  Less than 9,250
  9,250–16,000
  16,000–22,750
  22,750–29,500
  29,500–36,250
  36,250–43,000
  43,000–49,750
  49,750–56,500
  56,500–63,250
  63,250–70,000
  70,000–80,000
  Over 80000

The DALY is a summary measure that combines the impact of illness, disability, and mortality by measuring the time lived with disability and the time lost due to premature mortality. One DALY can be thought of as one lost year of "healthy" life. The DALY for a disease is the sum of the years of life lost due to premature mortality and the years lost due to disability for incident cases of the health condition.

Quality-adjusted life years

QALYs combine expected survival with expected quality of life into a single number: if an additional year of healthy life is worth a value of one (year), then a year of less healthy life is worth less than one (year). QALY calculations are based on measurements of the value that individuals place on expected years of survival. Measurements can be made in several ways: by techniques that replicate gambles about preferences for alternative states of health, with surveys or analyses that infer willingness to pay for alternative states of health, or through instruments that are based on trading off some or all likely survival time that a medical intervention might provide in order to gain less survival time of higher quality. [31]

Infant and child mortality

Infant mortality and child mortality for children under age 5 are more specific than DALYs or QALYs in representing the health in the poorest sections of a population, and are thus especially useful when focusing on health equity. [32] added section

Morbidity

Morbidity measures include incidence rate, prevalence, and cumulative incidence, with incidence rate referring to the risk of developing a new health condition within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during a time period, morbidity is better expressed as a proportion or a rate.

Health topics

Infectious diseases

Respiratory tract infections

Infections of the respiratory tract and middle ear are major causes of morbidity and mortality worldwide. [33] Some respiratory infections of global significance include tuberculosis, measles, influenza, coronaviruses and pneumonias caused by Mycobacterium tuberculosis , Morbillivirus , Haemophilus influenzae and Pneumococci respectively. The spread of respiratory infections is exacerbated by crowded conditions, and poverty is associated with more than a 20-fold increase in the relative burden of lung infections. [34]

Diarrheal illnesses

Diarrhea is the second most common cause of child mortality worldwide, responsible for 17% of deaths of children under age 5. [35] Poor sanitation can increase transmission of bacteria and viruses through water, food, utensils, hands, and flies. Dehydration due to diarrhea can be effectively treated through oral rehydration therapy with dramatic reductions in mortality. [36] [37] Important nutritional measures include the promotion of breastfeeding and zinc supplementation. While hygienic measures alone may be insufficient for the prevention of rotavirus diarrhea, [38] it can be prevented by a safe and potentially cost-effective vaccine. [39]

HIV/AIDS

The HIV/AIDS epidemic has highlighted the global nature of human health and welfare and globalization has given rise to a trend toward finding common solutions to global health challenges. Numerous international funds have been set up in recent times to address global health challenges such as HIV. [40] Since the beginning of the epidemic, more than 70 million people have been infected with the HIV virus and about 35 million people have died of HIV. Globally, 36.9 million [31.1–43.9 million] people were living with HIV at the end of 2017. An estimated 0.8% [0.6–0.9%] of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. The WHO African region remains most severely affected, with nearly 1 in every 25 adults (4.1%) living with HIV and accounting for nearly two-thirds of the people living with HIV worldwide. [41] Human immunodeficiency virus (HIV) is transmitted through unprotected sex, unclean needles, blood transfusions, and from mother to child during birth or lactation. Globally, HIV is primarily spread through sexual intercourse. The risk-per-exposure with vaginal sex in low-income countries from female to male is 0.38% and male to female is 0.3%. [42] The infection damages the immune system, leading to acquired immunodeficiency syndrome (AIDS) and eventually, death. Antiretroviral drugs prolong life and delay the onset of AIDS by minimizing the amount of HIV in the body.

Malaria

Malaria is a mosquito-borne infectious disease caused by the parasites of the genus Plasmodium . Symptoms may include fever, headaches, chills, muscle aches and nausea. Each year, there are approximately 500 million cases of malaria worldwide, most commonly among children and pregnant women in developing countries. [43] The WHO African Region carries a disproportionately high share of the global malaria burden. In 2016, the region was home to 90% of malaria cases and 91% of malaria deaths. [44] The use of insecticide-treated bed nets is a cost-effective way to reduce deaths from malaria, as is prompt artemisinin-based combination therapy, supported by intermittent preventive therapy in pregnancy. International travelers to endemic zones are advised chemoprophylaxis with antimalarial drugs like Atovaquone-proguanil, doxycycline, or mefloquine. [45] Global consumption and international trade in deforestation-associated commodities could also indirectly influence malaria risk. Many primary commodities cause deforestation and deforestation can increase malaria transmission. Consumption of such commodities in developed nations could increase malaria risk in developing nations. [46]

Bacterial pathogens

Global number of deaths (A) and YLLs (B), by pathogen and GBD super-region, 2019 Global number of deaths (A) and YLLs (B), by pathogen and GBD super-region, 2019.jpg
Global number of deaths (A) and YLLs (B), by pathogen and GBD super-region, 2019
Overall age-standardised mortality rate per 100 000 population for 33 pathogens investigated, 2019 Overall age-standardised mortality rate per 100 000 population for 33 pathogens investigated, 2019.jpg
Overall age-standardised mortality rate per 100 000 population for 33 pathogens investigated, 2019

A GBD study reported global estimates of death rates from (33) bacterial pathogens, finding such infections are contributing to one in 8 deaths (or ~7.7 million deaths), which could make it the second largest cause of death globally in 2019. [47]

Neglected tropical diseases

More than one billion people were treated for at least one neglected tropical disease in 2015. [48] For instance, neglected tropical diseases are a diverse group of infectious diseases that are endemic in tropical and subtropical regions of 149 countries, primarily effecting low and middle income populations in Africa, Asia, and Latin America. They are variously caused by bacteria (Trachoma, Leprosy), viruses (Dengue, [49] Rabies), protozoa (Human African trypanosomiasis, Chagas), and helminths (Schistosomiasis, Onchocerciasis, Soil transmitted helminths). [50] The Global Burden of Disease Study concluded that neglected tropical diseases comprehensively contributed to approximately 26.06 million disability-adjusted life years in 2010, as well as significant deleterious economic effects. [51] In 2011, the World Health Organization launched a 2020 Roadmap for neglected tropical diseases, aiming for the control or elimination of 10 common diseases. [52] The 2012 London Declaration builds on this initiative, and called on endemic countries and the international community to improve access to clean water and basic sanitation, improved living conditions, vector control, and health education, to reach the 2020 goals. [53] In 2017, a WHO report cited 'unprecedented progress' against neglected tropical diseases since 2007, especially due to mass drug administration of drugs donated by pharmaceutical companies. [54]

Pandemic prevention and preparedness

Pandemics have an impact on global health.


Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.

It is not to be mistaken for pandemic preparedness or mitigation (e.g. against COVID-19) which largely seek to mitigate the magnitude of negative effects of pandemics, although the topics may overlap with pandemic prevention in some respects.

Some biosafety and public health researchers contend that certain pandemic prevention efforts themselves carry risk of triggering pandemics (e.g. wildlife virus sampling), though not engaging in any form of sampling also carries the risk of being unprepared for future spillover events and being unaware of future pandemic pathogens.

Prevention of future pandemics requires steps to identify future causes of pandemics and to take preventive measures before the disease moves uncontrollably into the human population.

For example, influenza is a rapidly evolving disease which has caused pandemics in the past and has potential to cause future pandemics. WHO collates the findings of 144 national influenza centres worldwide which monitor emerging flu viruses. Virus variants which are assessed as likely to represent a significant risk are identified and can then be incorporated into the next seasonal influenza vaccine program. [55]

In a press conference on 28 December 2020, Mike Ryan, head of the WHO Emergencies Program, and other officials said the current COVID-19 pandemic is "not necessarily the big one" and "the next pandemic may be more severe." They called for preparation. [56] WHO and the UN have warned the world must tackle the cause of pandemics and not just the health and economic symptoms. [57]

Health research and development

The global health approach could foster international collaboration in medical research and development and share of its results such as vaccines, optimizing overall global health for citizens. The U.S. Agency for International Development's new Global Health Research and Development Strategy 2023-2028 includes plans to coordinate with such stakeholders in support of innovative global health product development and work with other agencies like the CDC and National Institutes of Health. Another approach to health would be the innovation of vaccines. The Washington Post reported the US government's new five billion dollar budget on vaccines to prevent Covid variants because the Vaccines' access and public-private partnerships are important. [58] Often the relevance of mechanisms to stimulate research and development is limited by national scopes and "by the transnational nature of the problem which asks for an international approach". [59] Financing models, creation of evidence-based recommendations, and logistics may be part of that. [60]

Maternal health

Complications of pregnancy and childbirth are the leading causes of death among women of reproductive age. In many developing countries, a woman dies from complications from childbirth approximately every minute. [61] According to the World Health Organization's 2005 World Health Report, poor maternal conditions are the fourth leading cause of death for women worldwide, after HIV/AIDS, malaria, and tuberculosis. [62] Most maternal deaths and injuries can be prevented, and such deaths have been largely eradicated in the developed world. [63] Targets for improving maternal health include increasing and assisting the number of deliveries accompanied by skilled birth attendants. [64] 68 low-income countries tracked by the WHO- and UNICEF-led collaboration Countdown to 2015 are estimated to hold for 97% of worldwide maternal and child deaths. [65]

Nutrition

In 2010, about 104 million children were underweight, and undernutrition contributes to about one third of child deaths around the world. [66] (Undernutrition is not to be confused with malnutrition , which refers to poor proportion of food intake and can thus refer to obesity.) [67] Undernutrition impairs the immune system, increasing the frequency, severity, and duration of infections (including measles, pneumonia, and diarrhea). Infection can further contribute to malnutrition. [68]

Deficiencies of micronutrients, such as vitamin A, iron, iodine, and zinc, are common worldwide and can compromise intellectual potential, growth, development, and adult productivity. [69] [70] [71] [72] [73] [74] [75] Interventions to prevent malnutrition include micronutrient supplementation, fortification of basic grocery foods, dietary diversification, hygienic measures to reduce spread of infections, and the promotion of breastfeeding.

Non-communicable diseases

Approximately 80% of deaths linked to non-communicable diseases occur in developing countries. [76] For instance, urbanization and aging have led to increasing poor health conditions related to non-communicable diseases in India. Similarly, China's rapid urbanization and modernization have been associated with increased sedentary lifestyles, contributing to the rise in NCDs in the region. [77] The fastest-growing causes of disease burden over the last 26 years were diabetes (rate increased by 80%) and ischemic heart disease (up 34%). More than 60% of deaths, about 6.1 million, in 2016 were due to NCDs, up from about 38% in 1990. [78] Increases in refugee urbanization, has led to a growing number of people diagnosed with chronic non-communicable diseases. [79]

In September 2011, the United Nations is hosting its first General Assembly Special Summit on the issue of non-communicable diseases. [80] Noting that non-communicable diseases are the cause of some 35 million deaths each year, the international community is being increasingly called to take measures for the prevention and control of chronic diseases and mitigate their impacts on the world population, especially on women, who are usually the primary caregivers.

For example, the rate of type 2 diabetes, associated with obesity, has been on the rise in countries previously troubled by hunger. In low-income countries, the number of individuals with diabetes is expected to increase from 84 million to 228 million by 2030. [81] Obesity, a preventable condition, is associated with numerous chronic diseases, including cardiovascular conditions, stroke, certain cancers, and respiratory disease. About 16% of the global burden of disease, measured as DALYs, has been accounted for by obesity. [81]

Considering that 360 million people across the world live with disabling hearing loss, including 32 million children and nearly 180 million older adults, and that chronic ear diseases, such as chronic suppurative otitis media, can lead to hearing loss and may cause life-threatening complications, the seventieth World Health Assembly on May 31, 2017 signed the resolution WHA70.13 (Agenda item 15.8) urging member states to integrate strategies for ear and hearing care within the framework of their primary health care systems, under the umbrella of universal health coverage. A World Report on Hearing (WRH) was published in response to the resolution (WHA70.13), to provide guidance for Member States to integrate ear and hearing care into their national health plans. [82]

Lifestyle diseases

Smoking cigarettes can lead to lung cancer, considered a lifestyle disease Debutantes in silhouette LCCN93505160.jpg
Smoking cigarettes can lead to lung cancer, considered a lifestyle disease

Lifestyle diseases can be defined as the diseases linked to the manner in which a person lives their life. These diseases are non-communicable, and can be caused by lack of physical activity, unhealthy eating, alcohol, substance use disorders and smoking tobacco, which can lead to heart disease, stroke, obesity, type II diabetes and lung cancer. [83] [84] The diseases that appear to increase in frequency as countries become more industrialized and people live longer include Alzheimer's disease, arthritis, atherosclerosis, asthma, cancer, chronic liver disease or cirrhosis, chronic obstructive pulmonary disease, colitis, irritable bowel syndrome, type 2 diabetes, heart disease, hypertension, metabolic syndrome, chronic kidney failure, osteoporosis, PCOD, stroke, depression, obesity and vascular dementia.

Concerns were raised in 2011 that lifestyle disease could soon have an impact on the workforce and the cost of health care. Treating these non-communicable diseases can be expensive. [85] It can be critical for the patients health to receive primary prevention and identify early symptoms of these non-communicable diseases. These lifestyle diseases are expected to increase throughout the years if people do not improve their lifestyle choices. [86]

Some commenters maintain a distinction between diseases of longevity and diseases of civilization or diseases of affluence. [87] Certain diseases, such as diabetes, dental caries and asthma, appear at greater rates in young populations living in the "western" way; their increased incidence is not related to age, so the terms cannot accurately be used interchangeably for all diseases. [88]

Commercial determinants of health refers to private sector activities that affect people's health positively or negatively such as advertisements for unhealthy food. [89]

Leading cause of death (2016) (world) Leading cause of death world.png
Leading cause of death (2016) (world)

The following is a list of the causes of human deaths worldwide for different years arranged by their associated mortality rates. In 2002, there were about 57 million deaths. In 2005, according to the World Health Organization (WHO) using the International Classification of Diseases (ICD), about 58 million people died. [90] In 2010, according to the Institute for Health Metrics and Evaluation, 52.8 million people died. [91] In 2016, the WHO recorded 56.7 million deaths [92] with the leading cause of death as cardiovascular disease causing more than 17 million deaths (about 31% of the total) as shown in the chart to the side.

Some causes listed include deaths also included in more specific subordinate causes, and some causes are omitted, so the percentages may only sum approximately to 100%. The causes listed are relatively immediate medical causes, but the ultimate cause of death might be described differently. For example, tobacco smoking often causes lung disease or cancer, and alcohol use disorder can cause liver failure or a motor vehicle accident. For statistics on preventable ultimate causes, see preventable causes of death.

Besides frequency, other measures to compare, consider and monitor trends of causes of deaths include disability-adjusted life year (DALY) and years of potential life lost (YPLL).
Global number of deaths (A) and YLLs (B), by bacterial pathogen (of 33) and GBD super-region, 2019 Global number of deaths (A) and YLLs (B), by pathogen and GBD super-region, 2019.jpg
Global number of deaths (A) and YLLs (B), by bacterial pathogen (of 33) and GBD super-region, 2019

Top causes of death, according to the World Health Organization report for the calendar year 2001: [94]

Causes of death in developing countries Number of deathsCauses of death in developed countries Number of deaths
HIV-AIDS 2,678,000 Ischaemic heart disease 3,512,000
Lower respiratory infections 2,643,000 Cerebrovascular disease 3,346,000
Ischaemic heart disease 2,484,000 Chronic obstructive pulmonary disease 1,829,000
Diarrhea 1,793,000 Lower respiratory infections 1,180,000
Cerebrovascular disease 1,381,000 Lung cancer 938,000
Childhood diseases 1,217,000 Car crash 669,000
Malaria 1,103,000 Stomach cancer 657,000
Tuberculosis 1,021,000 Hypertensive heart disease 635,000
Chronic obstructive pulmonary disease 748,000 Tuberculosis 571,000
Measles 674,000 Suicide 499,000

Violence against women

Violence against women has been defined as: "physical, sexual and psychological violence occurring in the family and in the general community, including battering, sexual abuse, dowry-related violence, rape, female genital mutilation and other traditional practices harmful to women, non-spousal violence and violence related to exploitation, sexual harassment and intimidation at work, in educational institutions and elsewhere, trafficking in women, forced prostitution and violence perpetrated or condoned by the state." [95] In addition to causing injury, violence may increase "women's long-term risk of a number of other health problems, including chronic pain, physical disability, drug and alcohol abuse, and depression". [96] The WHO Report on global and regional estimates on violence against women found that partner abuse causes women to have 16% more chances of suffering miscarriages, 41% more occurrences of pre-term birth babies and twice the likeliness of having abortions and acquiring HIV or other STDs [97]

Although statistics can be difficult to obtain as many cases go unreported, it is estimated that one in every five women faces some form of violence during her lifetime, in some cases leading to serious injury or even death. [98] Risk factors for being an offender include low education, past exposure to child maltreatment or witnessing violence between parents, harmful use of alcohol, attitudes accepting of violence, and gender inequality. [99] Equality of women has been addressed in the Millennium development goals. Now, Gender Equality is Sustainable Development Goal 5. Preventing the violence against women needs to form an essential part of the public health reforms in the form of advocation and evidence gathering. Primary prevention in the form of raising women economic empowerment facilities, microfinance and skills training social projects related to gender equality should be conducted.

Activities promoting relationship and communication skills among couples, reducing alcohol access and altering societal ideologies should be organized. Childhood interventions, community and school-based education, raising media-oriented awareness and other approaches should be carried out to challenge social norms and stereotypical thought processes to promote behavioral change among men and raise gender equality. Trained health care providers would play a vital role in secondary and tertiary prevention of abuse by performing early identification of women suffering from violence and contributing to the addressing of their health and psychological needs. They could be highly important in prevention of the recurrence of violence and the mitigation of its effects on the health of the abused women and their children. [100] The Member States of the World Health Assembly endorsed a plan in 2016 for reinforcing the health system's role in addressing the global phenomenon of violence against women and girls and working towards their health and protection. [101]

Global surgery

Halfdan T. Mahler, the 3rd Director-General of the World Health Organization (WHO), first brought attention to the disparities in surgery and surgical care when he stated, "‘the vast majority of the world’s population has no access whatsoever to skilled surgical care and little is being done to find a solution,". [102]

While significant progresses have been made in fields within global health such as infectious diseases, maternal and child health, and even other non-communicable diseases over the past several decades, the provision of surgery and surgical care in resource-limited settings have largely remained unmet with about 5 billion people lacking access to safe and affordable surgical and anesthesia care. [103] This is especially true in the poorest countries, which account for over one-third of the population but only 3.5% of all surgeries that occur worldwide. [104] In fact, it has been estimated that up to 30% of the total global burden of disease (GBD) could be attributable to surgical conditions, which include a mix of injuries, malignancies, congenital anomalies, and complications of pregnancy. [105] [106] As a result, global surgery has become an emerging field within global health as 'the multidisciplinary enterprise of providing improved and equitable surgical care to the world's population, with its core belief as the issues of need, access and quality' and has often been described as the 'neglected stepchild of global health,' a term coined by Dr. Paul Farmer to highlight the urgent need for further work in this area. [107] [108] Furthermore, Jim Young Kim, the former President of the World Bank, proclaimed in 2014 that “surgery is an indivisible, indispensable part of health care and of progress towards universal health coverage." [109]

In 2015, the Lancet Commission on Global Surgery (LCoGS) published the landmark report titled "Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development," describing the large, pre-existing burden of surgical diseases in low- and middle-income countries (LMICs) and future directions for increasing universal access to safe surgery by the year 2030. [103] The Commission highlighted that 143 million additional procedures were needed every year to prevent further morbidity and mortality from treatable surgical conditions as well as a $12.3 trillion loss in economic productivity by the year 2030. [103] It emphasized the need to significantly improve the capacity for Bellwether procedures – laparotomy, caesarean section, open fracture care – which are considered a minimum level of care that first-level hospitals should be able to provide in order to capture the most basic emergency surgical care. [103] [110] In order to address these challenges and track progress, the Commission defined the following core indicators for assessing access to safe and affordable surgical d anesthesia care: [103]

Core IndicatorsDefinitionTarget
Access to timely essential surgeryThe proportion of the population that can access, within 2 hours, a facility that can do cesarean delivery, laparotomy, and treatment of open fracture (the Bellwether Procedures)A minimum of 80% coverage of essential surgical and anesthesia services per country by 2030
Specialist surgical workforce densityThe number of specialist surgical, anaesthetic, and obstetric physicians who are working, per 100,000 population100% of countries with at least 20 surgical, anaesthetic, and obstetric physicians per 100, 000 population by 2030
Surgical volumeThe number of procedures done in an operating theatre, per 100,000 population per year80% of countries by 2020 and 100% of countries by 2030 tracking surgical volume; a minimum of 5000 procedures per 100,000 population by 2030
Perioperative mortalityAll-cause death rate before discharge in patients who have undergone a procedure in an operating theatre, divided by the total number of procedures, presented as a percentage80% of countries by 2020 and 100% of countries by 2030 tracking perioperative mortality; in 2020, assess global data and set national targets for 2030
Protection against impoverishing expenditureThe proportion of households protected against impoverishment from direct out-of-pocket payments for surgical and anesthesia care100% protection against impoverishment from out-of-pocket payments for surgical and anaesthesia care by 2030
Protection against catastrophic expenditureThe proportion of households protected against catastrophic expenditure from direct out-of-pocket payments for surgical and anesthesia care100% protection against catastrophic expenditure from out-of-pocket payments for surgical and anaesthesia care by 2030

Meeting these goals by the year 2030 would require increases in anesthetists, obstetricians, surgeons, nurses, and facilities with operating rooms as well as pre- and post-surgical care capacities.

Data from WHO and the World Bank indicate that scaling up infrastructure to enable access to surgical care in regions where it is currently limited or is non-existent is a low-cost measure relative to the significant morbidity and mortality caused by lack of surgical treatment. [105] In fact, a systematic review found that the cost-effectiveness ratio – dollars spent per DALYs averted – for surgical interventions is on par or exceeds those of major public health interventions such as oral rehydration therapy, breastfeeding promotion, and even HIV/AIDS antiretroviral therapy. [111] This finding challenged the common misconception that surgical care is financially prohibitive endeavor not worth pursuing in LMICs.

In terms of the financial impact on the patients, the lack of adequate surgical and anesthesia care has resulted in 33 million individuals every year facing catastrophic health expenditure – the out-of-pocket healthcare cost exceeding 40% of a given household's income. [103] [112]

In alignment with the LCoGS call for action, the World Health Assembly adopted the resolution WHA68.15 in 2015 that stated, "Strengthening emergency and essential surgical care and anesthesia as a component of universal health coverage." [113] This not only mandated the WHO to prioritize strengthening the surgical and anesthesia care globally, but also led to governments of the member states recognizing the urgent need for increasing capacity in surgery and anesthesia. Additionally, the third edition of Disease Control Priorities (DCP3), published in 2015 by the World Bank, declared surgery as essential and featured an entire volume dedicated to building surgical capacity. [114]

A key policy framework that arose from this renewed global commitment towards surgical care worldwide is the National Surgical Obstetric and Anesthesia Plan (NSOAP). [115] NSOAP focuses on policy-to-action capacity building for surgical care with tangible steps as follows: (1) analysis of baseline indicators, (2) partnership with local champions, (3) broad stakeholder engagement, (4) consensus building and synthesis of ideas, (5) language refinement, (6) costing, (7) dissemination, and (8) implementation. This approach has been widely adopted and has served as guiding principles between international collaborators and local institutions and governments. Successful implementations have allowed for sustainability in terms of longterm monitoring, quality improvement, and continued political and financial support. [115]

The NIHR Global Health Research Unit on Global Surgery

Seven surgical research Hubs in Benin, Ghana, India, Mexico, Nigeria, Rwanda and South Africa with an extensive network of urban and rural ‘Spoke’ hospitals have joined to create the NIHR. [116] The NIHR Global Health Research Unit on Global Surgery is led by the University of Birmingham [117] which provides overall oversight in relation to the Unit strategy, infrastructure and delivery, research and finance.

The network prioritized surgical topics that needed research and has performed multiple surgical studies. The network resulted in many research groups including GlobalSurg I, II, III [118] and COVIDSurg [119] and many other trials with worldwide collaborations as project FALCON [120] and CHEETAH. [121]

The research was published in over 40 articles in high impact journals in topics like Surgical site infections, [122] COVID-19 [123] and mortality. [124]

Other Global Surgery Collaborations

More trials have emerged to assess surgical outcomes around the World using big data from thousands of centers. Other notable trials include:

  • Global PaedSurg; The study was published in The Lancet examined the risk of mortality for nearly 4000 babies born with birth defects in 264 hospitals around the world. The study found babies born with birth defects involving the intestinal tract have a two in five chance of dying in a low-income country compared to one in five in a middle-income country and one in twenty in a high-income country. [125] [126]
  • APORG: The African Perioperative Research Group (APORG) was launched in South Africa
  • ASOS and ASOS-2; The studies showed that death after surgery is a major public health problem in Africa. Surgical patients in Africa are twice as likely to die in hospital following surgery when compared to the global average. [127] [128]
  • ACCCOS
  • Global Health Research Group on Children’s Non-Communicable Diseases Collaborative

Many scholars from around the world have participated in overlapping trials whether as Principal Investigators, Dissemination Committee or Regional leaders to promote the research and oversee data collection. Notable collaborators from these networks include The list included key figures from around the World as Prof Bruce Biccard (South Africa), Prof Adesoji Ademuyiwa (Nigeria), Prof Kokila Lakhoo (Oxford, UK), Dr Naomi Wright (Oxford, UK), Dr Emrah Aydin (Turkey), Prof Mahmoud Elfiky (Egypt) and Prof Milind Chitnis (South Africa). [129]

Multimorbidity is "a growing public health problem worldwide", "likely driven by the ageing population but also by factors such as high body-mass index, urbanisation, and the growing burden of NCDs (such as type 2 diabetes) and tuberculosis in low- and middle-income countries (LMICs)". [130] [131] [132] Around the world, many people do not die from one isolated condition but from a multitude of factors and conditions.[ additional citation(s) needed ] A study suggested there is a paucity of multimorbidity and comorbidity data globally and mapped comorbidity patterns. [133]

With aging populations, there is a rise of age-related diseases which puts major burdens on healthcare systems as well as contemporary economies or contemporary economics and their appendant societal systems. Healthspan extension and anti-aging research seek to extend the span of health in the old as well as slow aging or its negative impacts such as physical and mental decline. Modern anti-senescent and regenerative technology with augmented decision making could help "responsibly bridge the healthspan-lifespan gap for a future of equitable global wellbeing". [134] Aging is "the most prevalent risk factor for chronic disease, frailty and disability, and it is estimated that there will be over 2 billion persons age > 60 by the year 2050", making it a large global health challenge that demands substantial (and well-orchestrated or efficient) efforts, including interventions that alter and target the inborn aging process. [135]

Infertility crisis

A scientific review found that human sperm counts fell by 62% in the last 50 years, are decreasing at an accelerating rate and are decreasing worldwide, [136] [137] likely a result of factors such as poor diets, endocrine disruptors in prevalent products, unhealthy lifestyles and toxic forever chemicals in air and water. [136]

Health interventions

Global interventions for improved child health and survival include the promotion of breastfeeding, zinc supplementation, vitamin A fortification, salt iodization, hygiene interventions such as hand-washing, vaccinations, and treatments of severe acute malnutrition. [64] [138] [139] The Global Health Council suggests a list of 32 treatments and health interventions that could potentially save several million lives each year. [140]

Many populations face an "outcome gap", which refers to the gap between members of a population who have access to medical treatment versus those who do not. Countries facing outcome gaps lack sustainable infrastructure. [141] In Guatemala, a subset of the public sector, the Programa de Accessibilidad a los Medicamentos ("Program for Access to Medicines"), had the lowest average availability (25%) compared to the private sector (35%). In the private sector, the highest- and lowest-priced medicines were 22.7 and 10.7 times more expensive than international reference prices respectively. Treatments were generally unaffordable, costing as much as 15 days wages for a course of the antibiotic ceftriaxone. [142] The public sector in Pakistan, while having access to medicines at a lower price than international reference prices, has a chronic shortage of and lack of access to basic medicines. [143]

Journalist Laurie Garrett argues that the field of global health is not plagued by a lack of funds, but that more funds do not always translate into positive outcomes. The problem lies in the way these funds are allocated, as they are often disproportionately allocated to alleviating a single disease. [144]

Labor shortages

In its 2006 World Health Report, the WHO estimated a shortage of almost 4.3 million doctors, midwives, nurses, and support workers worldwide, especially in sub-Saharan Africa. [145] A 2022 study estimated that, "in 2019, the world had 104.0 million (95% uncertainty interval 83.5–128.0) health workers, including 12.8 million (9.7–16.6) physicians, 29.8 million (23.3–37.7) nurses and midwives, 4.6 million (3.6–6.0) dentistry personnel, and 5.2 million (4.0–6.7) pharmaceutical personnel" and found that sub-Saharan Africa, south Asia, and north Africa and the Middle East had the lowest densities of human resources for health. [146] However, even when only considering current technologies and processes (such as only little use of telehealth as of 2022), overall numbers of personnel and shortages don't consider sub-national geographic distribution of various types of health workers (or expertise).

Global health security

The COVID-19 pandemic has highlighted how global health security is reliant on all countries around the world, including low- and middle-income countries, having strong health systems and at least a minimum of health research capacities. In an article 2020 in Annals of Global Health, [147] the ESSENCE group outlined a mechanism for review of investment in health research capacity building in low- and middle-income countries. The review mechanism will give funders of research for health the information to identify the gaps in the capacity that exist in low- and middle-income countries and the opportunity to work together to address those disparities. The overall goal is increased, coordinated support of research on national health priorities as well as improved pandemic preparedness in LMICs, and, eventually, fewer countries with very limited health research capacity.

Global factors impacting health

Climate change

Heat stroke treatment at Baton Rouge during 2016 Louisiana floods. Climate change is making heat waves more common, potentially leading to a higher risk of heat stroke. Heat stroke treatment, Baton Rouge, 2016 Louisiana floods.jpg
Heat stroke treatment at Baton Rouge during 2016 Louisiana floods. Climate change is making heat waves more common, potentially leading to a higher risk of heat stroke.

The effects of climate change on human health are increasingly well studied and quantified. [148] [149] Rising temperatures and changes in weather patterns are increasing the frequency and severity of heat waves, wildfires, droughts, floods, landslides, hurricanes, and other causes of injury and illness. Heat waves and extreme weather events have a big impact on health both directly and indirectly. Direct effects of exposure to high and extended temperatures include illness, reduced labour capacity for outdoor workers, and heat-related mortality. [150]

In addition to direct impacts, climate change and extreme weather events cause changes in the biosphere. Climate-sensitive pathogens and vector-borne diseases may increase in some regions. Changes in temperature are creating conditions favorable to mosquito-borne diseases such as dengue fever, and waterborne diseases including diarrhoeal disease. [150] [151] Climate change will impact where infectious diseases are able to spread in the future. Many infectious diseases will spread to new geographic areas where people have not previously been exposed or developed immunity. [152] [153]

Changes in climate can cause decreasing yields for some crops and regions, resulting in higher food costs, food insecurity, and undernutrition. Water insecurity is also an additional concern. Increases in poverty, displacement, migration, violent conflict, and negative effects on mental health are all occurring. [154] [155] [150]

Climate change affects human health at all ages, from infancy through adolescence, adulthood and old age. [154] [150] Factors such as age, gender and socioeconomic status influence to what extent these effects become wide-spread risks to human health. [155] :1867 Extreme weather creates physical and economic risks for whole families, particularly those families headed by women. Temperature and heatwaves affect the earning capacity and economic stability of individuals and households. Populations over 65 years of age are particularly vulnerable to heat and other health effects of climate change. [154] Health risks are unevenly distributed across the world. [155] Disadvantaged populations are especially vulnerable to climate change effects. [150] :15

The health effects of climate change are increasingly a matter of concern for the international public health policy community. In 2009, a publication in the general medical journal The Lancet stated that "Climate change is the biggest global health threat of the 21st century". [156] The World Health Organization reiterated this in 2015. [157] In 2019, the Australian Medical Association formally declared climate change as a health emergency. [158]

Research shows that health professionals around the world agree that climate change is real, is caused by humans, and is causing increased health problems in their communities. Studies also show that taking action to address climate change improves public health. Health professionals can act by informing people about health harms and ways to address them, by lobbying leaders to take action, and by taking steps to decarbonize their own homes and workplaces. [159]

Studies have found that communications on climate change that present it as a health concern rather than just an environmental matter are more likely to engage the public. [160] [161]

A comprehensive annually scheduled study finds climate change is "undermining every dimension of global health monitored" and reports dire conclusions from tracking of impact indicators. [162] [163] The effects of climate change have also increased the risk of health conditions, such as lung disease or asthma which are caused by air pollution. [164] These medical conditions are caused due to extreme heatwaves or by "higher concentrations of ground-level ozone". [164]

Antimicrobial resistance


Antibiotic resistance tests: Bacteria are streaked on dishes with white disks, each impregnated with a different antibiotic. Clear rings, such as those on the left, show that bacteria have not grown--indicating that these bacteria are not resistant. The bacteria on the right are fully resistant to three of seven and partially resistant to two of seven antibiotics tested. Antibiotic sensitivity and resistance.jpg
Antibiotic resistance tests: Bacteria are streaked on dishes with white disks, each impregnated with a different antibiotic. Clear rings, such as those on the left, show that bacteria have not grown—indicating that these bacteria are not resistant. The bacteria on the right are fully resistant to three of seven and partially resistant to two of seven antibiotics tested.

Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials (drugs used to treat infections). [166] All classes of microbes can evolve resistance where the drugs are no longer effective. Fungi evolve antifungal resistance, viruses evolve antiviral resistance, protozoa evolve antiprotozoal resistance, and bacteria evolve antibiotic resistance. Together all of these come under the umbrella of antimicrobial resistance. Microbes resistant to multiple antimicrobials are called multidrug resistant (MDR) and are sometimes referred to as superbugs. [167] Although antimicrobial resistance is a naturally occurring process, it is often the result of improper usage of the drugs and management of the infections. [168] [169]

Antibiotic resistance is a major subset of AMR, that applies specifically to bacteria that become resistant to antibiotics. [166] Resistance in bacteria can arise naturally by genetic mutation, or by one species acquiring resistance from another. [170] Resistance can appear spontaneously because of random mutations, but also arises through spreading of resistant genes through horizontal gene transfer. However, extended use of antibiotics appears to encourage selection for mutations which can render antibiotics ineffective. [171] Antifungal resistance is a subset of AMR, that specifically applies to fungi that have become resistant to antifungals. Resistance to antifungals can arise naturally, for example by genetic mutation or through aneuploidy. Extended use of antifungals leads to development of antifungal resistance through various mechanisms. [172]

Clinical conditions due to infections caused by microbes containing AMR cause millions of deaths each year. [173] In 2019 there were around 1.27 million deaths globally caused by bacterial AMR. [174] Infections caused by resistant microbes are more difficult to treat, requiring higher doses of antimicrobial drugs, more expensive antibiotics, or alternative medications which may prove more toxic. These approaches may also cost more. [168] [169]

The prevention of antibiotic misuse, which can lead to antibiotic resistance, includes taking antibiotics only when prescribed. [175] [176] Narrow-spectrum antibiotics are preferred over broad-spectrum antibiotics when possible, as effectively and accurately targeting specific organisms is less likely to cause resistance, as well as side effects. [177] [178] [179] For people who take these medications at home, education about proper use is essential. Health care providers can minimize spread of resistant infections by use of proper sanitation and hygiene, including handwashing and disinfecting between patients, and should encourage the same of the patient, visitors, and family members. [180]

Rising drug resistance is caused mainly by use of antimicrobials in humans and other animals, and spread of resistant strains between the two. [175] Growing resistance has also been linked to releasing inadequately treated effluents from the pharmaceutical industry, especially in countries where bulk drugs are manufactured. [181] Antibiotics increase selective pressure in bacterial populations, killing vulnerable bacteria; this increases the percentage of resistant bacteria which continue growing. Even at very low levels of antibiotic, resistant bacteria can have a growth advantage and grow faster than vulnerable bacteria. [182] Similarly, the use of antifungals in agriculture increases selective pressure in fungal populations which triggers the emergence of antifungal resistance. [172] As resistance to antimicrobials becomes more common there is greater need for alternative treatments. Calls for new antimicrobial therapies have been issued, but there is very little development of new drugs which would lead to an improved research process. [183]

Antimicrobial resistance is increasing globally due to increased prescription and dispensing of antibiotic drugs in developing countries. [184] Estimates are that 700,000 to several million deaths result per year and continues to pose a major public health threat worldwide. [185] [186] [187] Each year in the United States, at least 2.8 million people become infected with bacteria that are resistant to antibiotics and at least 35,000 people die and US$55 billion is spent on increased health care costs and lost productivity. [188] [189] According to World Health Organization (WHO) estimates, 350 million deaths could be caused by AMR by 2050. [190] By then, the yearly death toll will be 10 million, according to a United Nations report. [191]

There are public calls for global collective action to address the threat that include proposals for international treaties on antimicrobial resistance. [192] The burden of worldwide antibiotic resistance is not completely identified, but low-and middle- income countries with weaker healthcare systems are more affected, with mortality being the highest in sub-Saharan Africa. [174] [176] During the COVID-19 pandemic, priorities changed with action against antimicrobial resistance slowing due to scientists and governments focusing more on SARS-CoV-2 research. [193] [194] At the same time the threat of AMR has increased during the pandemic. [195]

AMR has been described as a leading global health issue. Globally, 1.27 million deaths in 2019 were attributable to AMR. That year, AMR may have contributed to 5 million deaths and one in five people who died due to AMR were children under five years old. [196]

Organization

Governmental or inter-governmental organizations focused on global health include:

Non-governmental organizations focused on global health include:

Governments and analysis

A study of select global health related organizations and initiatives suggests that major trends in global health governance appear to be "towards more discretionary funding and away from core or longer-term funding; towards defined multi-stakeholder governance and away from traditional government-centred representation and decision-making; and towards narrower mandates or problem-focused vertical initiatives and away from broader systemic goals". [197] There is a growing willingness to use militaries in state-led support of global health efforts which have capabilities ranging from "research, surveillance, and medical expertise to rapidly deployable, large-scale assets for logistics, transportation, and security". [198]

Global Health Security Agenda

The Global Health Security Agenda (GHSA) is "a multilateral, multi-sector effort that includes 60 participating countries and numerous private and public international organizations focused on building up worldwide health security capabilities toward meeting such threats" as the spread of infectious disease. On March 26–28, 2018, the GHSA held a high-level meeting in Tbilisi, Georgia, on biosurveillance of infectious disease threats, "which include such modern-day examples as HIV/AIDS, severe acute respiratory syndrome (SARS), H1N1 influenza, multi-drug resistant tuberculosis — any emerging or reemerging disease that threatens human health and global economic stability". [199] This event brought together GHSA partner countries, contributing countries of Real-Time Surveillance Action Package, and international partner organizations supporting the strengthening of capacities to detect infectious disease threats within the Real-Time Surveillance Action Package and other cross-cutting packages. [200]

GHSA works through four main mechanisms of member action, action packages, task forces and international cooperation. In 2015, the Steering Group of the GHSA agreed upon the implementation of their commitments through 11 Action Packages. Action Packages are a commitment by member countries and their partners to work collaboratively towards development and implementation of International Health Regulations (IHR). [201] Action packages are based on GHSA's aim to strengthen national and international capacity to prevent, detect, and respond to infectious disease threats. Each action package consists of five-year targets, measures of progress, desired impacts, country commitments, and list of baseline assessments. [202] The Joint External Evaluation process, derived as part of the IHR Monitoring and Evaluation Framework is an assessment of a country's capacity for responding to public health threats. [201] So far, G7 partners and EU have made a collective commitment to assist 76 countries whereas the US committed to helping 32 countries to achieve GHSA targets for IHR implementation. In September 2014, a pilot tool was developed to measure progress of the Action Packages and applied in countries (Georgia, Peru, Uganda, Portugal, the United Kingdom, and Ukraine) that volunteered to participate in an external assessment. [203]

See also

Notes

    Related Research Articles

    <span class="mw-page-title-main">Antibiotic</span> Antimicrobial substance active against bacteria

    An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the ones which cause the common cold or influenza; drugs which inhibit growth of viruses are termed antiviral drugs or antivirals rather than antibiotics. They are also not effective against fungi; drugs which inhibit growth of fungi are called antifungal drugs.

    <span class="mw-page-title-main">Antimicrobial resistance</span> Resistance of microbes to drugs directed against them

    Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials. All classes of microbes can evolve resistance where the drugs are no longer effective. Fungi evolve antifungal resistance, viruses evolve antiviral resistance, protozoa evolve antiprotozoal resistance, and bacteria evolve antibiotic resistance. Together all of these come under the umbrella of antimicrobial resistance. Microbes resistant to multiple antimicrobials are called multidrug resistant (MDR) and are sometimes referred to as superbugs. Although antimicrobial resistance is a naturally occurring process, it is often the result of improper usage of the drugs and management of the infections.

    <span class="mw-page-title-main">Chlamydia</span> Sexually transmitted infection caused by the bacterium Chlamydia trachomatis

    Chlamydia, or more specifically a chlamydia infection, is a sexually transmitted infection caused by the bacterium Chlamydia trachomatis. Most people who are infected have no symptoms. When symptoms do appear they may occur only several weeks after infection; the incubation period between exposure and being able to infect others is thought to be on the order of two to six weeks. Symptoms in women may include vaginal discharge or burning with urination. Symptoms in men may include discharge from the penis, burning with urination, or pain and swelling of one or both testicles. The infection can spread to the upper genital tract in women, causing pelvic inflammatory disease, which may result in future infertility or ectopic pregnancy.

    <span class="mw-page-title-main">Rheumatic fever</span> Post-streptococcal inflammatory disease

    Rheumatic fever (RF) is an inflammatory disease that can involve the heart, joints, skin, and brain. The disease typically develops two to four weeks after a streptococcal throat infection. Signs and symptoms include fever, multiple painful joints, involuntary muscle movements, and occasionally a characteristic non-itchy rash known as erythema marginatum. The heart is involved in about half of the cases. Damage to the heart valves, known as rheumatic heart disease (RHD), usually occurs after repeated attacks but can sometimes occur after one. The damaged valves may result in heart failure, atrial fibrillation and infection of the valves.

    <span class="mw-page-title-main">Upper respiratory tract infection</span> Medical condition

    An upper respiratory tract infection (URTI) is an illness caused by an acute infection, which involves the upper respiratory tract, including the nose, sinuses, pharynx, larynx or trachea. This commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. Most infections are viral in nature, and in other instances, the cause is bacterial. URTIs can also be fungal or helminthic in origin, but these are less common.

    <span class="mw-page-title-main">Lower respiratory tract infection</span> Medical term

    Lower respiratory tract infection (LRTI) is a term often used as a synonym for pneumonia but can also be applied to other types of infection including lung abscess and acute bronchitis. Symptoms include shortness of breath, weakness, fever, coughing and fatigue. A routine chest X-ray is not always necessary for people who have symptoms of a lower respiratory tract infection.

    Perioperative mortality has been defined as any death, regardless of cause, occurring within 30 days after surgery in or out of the hospital. Globally, 4.2 million people are estimated to die within 30 days of surgery each year. An important consideration in the decision to perform any surgical procedure is to weigh the benefits against the risks. Anesthesiologists and surgeons employ various methods in assessing whether a patient is in optimal condition from a medical standpoint prior to undertaking surgery, and various statistical tools are available. ASA score is the most well known of these.

    <span class="mw-page-title-main">Obstructed labour</span> Medical condition

    Obstructed labour, also known as labour dystocia, is the baby not exiting the pelvis because it is physically blocked during childbirth although the uterus contracts normally. Complications for the baby include not getting enough oxygen which may result in death. It increases the risk of the mother getting an infection, having uterine rupture, or having post-partum bleeding. Long-term complications for the mother include obstetrical fistula. Obstructed labour is said to result in prolonged labour, when the active phase of labour is longer than 12 hours.

    Enterotoxigenic Escherichia coli (ETEC) is a type of Escherichia coli and one of the leading bacterial causes of diarrhea in the developing world, as well as the most common cause of travelers' diarrhea. Insufficient data exists, but conservative estimates suggest that each year, about 157,000 deaths occur, mostly in children, from ETEC. A number of pathogenic isolates are termed ETEC, but the main hallmarks of this type of bacterium are expression of one or more enterotoxins and presence of fimbriae used for attachment to host intestinal cells. The bacterium was identified by the Bradley Sack lab in Kolkata in 1968.

    <span class="mw-page-title-main">Paratyphoid fever</span> Bacterial infection caused by one of the three types of Salmonella enterica

    Paratyphoid fever, also known simply as paratyphoid, is a bacterial infection caused by one of three types of Salmonella enterica. Symptoms usually begin 6–30 days after exposure and are the same as those of typhoid fever. Often, a gradual onset of a high fever occurs over several days. Weakness, loss of appetite, and headaches also commonly occur. Some people develop a skin rash with rose-colored spots. Without treatment, symptoms may last weeks or months. Other people may carry the bacteria without being affected; however, they are still able to spread the disease to others. Typhoid and paratyphoid are of similar severity. Paratyphoid and typhoid fever are types of enteric fever.

    The Global Burden of Disease Study (GBD) is a comprehensive regional and global research program of disease burden that assesses mortality and disability from major diseases, injuries, and risk factors. GBD is a collaboration of over 3600 researchers from 145 countries. Under principal investigator Christopher J.L. Murray, GBD is based in the Institute for Health Metrics and Evaluation (IHME) at the University of Washington and funded by the Bill and Melinda Gates Foundation.

    <span class="mw-page-title-main">Pathogenic bacteria</span> Disease-causing bacteria

    Pathogenic bacteria are bacteria that can cause disease. This article focuses on the bacteria that are pathogenic to humans. Most species of bacteria are harmless and are often beneficial but others can cause infectious diseases. The number of these pathogenic species in humans is estimated to be fewer than a hundred. By contrast, several thousand species are part of the gut flora present in the digestive tract.

    <span class="mw-page-title-main">Gonorrhea</span> Sexually transmitted infection

    Gonorrhoea or gonorrhea, colloquially known as the clap, is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. Infection may involve the genitals, mouth, or rectum. Infected men may experience pain or burning with urination, discharge from the penis, or testicular pain. Infected women may experience burning with urination, vaginal discharge, vaginal bleeding between periods, or pelvic pain. Complications in women include pelvic inflammatory disease and in men include inflammation of the epididymis. Many of those infected, however, have no symptoms. If untreated, gonorrhea can spread to joints or heart valves.

    <span class="mw-page-title-main">Iatrogenesis</span> Causation of harm by any medical activity

    Iatrogenesis is the causation of a disease, a harmful complication, or other ill effect by any medical activity, including diagnosis, intervention, error, or negligence. First used in this sense in 1924, the term was introduced to sociology in 1976 by Ivan Illich, alleging that industrialized societies impair quality of life by overmedicalizing life. Iatrogenesis may thus include mental suffering via medical beliefs or a practitioner's statements. Some iatrogenic events are obvious, like amputation of the wrong limb, whereas others, like drug interactions, can evade recognition. In a 2013 estimate, about 20 million negative effects from treatment had occurred globally. In 2013, an estimated 142,000 persons died from adverse effects of medical treatment, up from an estimated 94,000 in 1990.

    <span class="mw-page-title-main">Institute for Health Metrics and Evaluation</span> Statistics institute for public health under the University of Washington, based in Seattle

    The Institute for Health Metrics and Evaluation (IHME) is a research institute working in the area of global health statistics and impact evaluation at the University of Washington in Seattle. The Institute is headed by Christopher J.L. Murray, a physician and health economist, and professor at the University of Washington Department of Global Health, which is part of the School of Medicine. IHME conducts research and trains scientists, policymakers, and the public in health metrics concepts, methods, and tools. Its mission includes judging the effectiveness and efficacy of health initiatives and national health systems. IHME also trains students at the post-baccalaureate and post-graduate levels.

    Didier Pittet is an infectious diseases expert and the director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospital of Geneva, Geneva, Switzerland. Since 2005, Pittet is also the External Lead of the World Health Organization (WHO) Global Patient Safety Challenge "Clean Care is Safer Care" and African Partnerships for Patient Safety.

    Postoperative wounds are those wounds acquired during surgical procedures. Postoperative wound healing occurs after surgery and normally follows distinct bodily reactions: the inflammatory response, the proliferation of cells and tissues that initiate healing, and the final remodeling. Postoperative wounds are different from other wounds in that they are anticipated and treatment is usually standardized depending on the type of surgery performed. Since the wounds are 'predicted' actions can be taken beforehand and after surgery that can reduce complications and promote healing.

    ESKAPE is an acronym comprising the scientific names of six highly virulent and antibiotic resistant bacterial pathogens including: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. The acronym is sometimes extended to ESKAPEE to include Escherichia coli. This group of Gram-positive and Gram-negative bacteria can evade or 'escape' commonly used antibiotics due to their increasing multi-drug resistance (MDR). As a result, throughout the world, they are the major cause of life-threatening nosocomial or hospital-acquired infections in immunocompromised and critically ill patients who are most at risk. P. aeruginosa and S. aureus are some of the most ubiquitous pathogens in biofilms found in healthcare. P. aeruginosa is a Gram-negative, rod-shaped bacterium, commonly found in the gut flora, soil, and water that can be spread directly or indirectly to patients in healthcare settings. The pathogen can also be spread in other locations through contamination, including surfaces, equipment, and hands. The opportunistic pathogen can cause hospitalized patients to have infections in the lungs, blood, urinary tract, and in other body regions after surgery. S. aureus is a Gram-positive, cocci-shaped bacterium, residing in the environment and on the skin and nose of many healthy individuals. The bacterium can cause skin and bone infections, pneumonia, and other types of potentially serious infections if it enters the body. S. aureus has also gained resistance to many antibiotic treatments, making healing difficult. Because of natural and unnatural selective pressures and factors, antibiotic resistance in bacteria usually emerges through genetic mutation or acquires antibiotic-resistant genes (ARGs) through horizontal gene transfer - a genetic exchange process by which antibiotic resistance can spread.

    References

    1. Brown TM, Cueto M, Fee E (January 2006). "The World Health Organization and the transition from "international" to "global" public health". American Journal of Public Health. 96 (1): 62–72. doi:10.2105/AJPH.2004.050831. PMC   1470434 . PMID   16322464.
    2. Koplan JP, Bond TC, Merson MH, Reddy KS, Rodriguez MH, Sewankambo NK, Wasserheit JN (June 2009). "Towards a common definition of global health". Lancet. 373 (9679): 1993–1995. CiteSeerX   10.1.1.610.7968 . doi:10.1016/S0140-6736(09)60332-9. PMC   9905260 . PMID   19493564. S2CID   6919716.
    3. Global Health Initiative (2008). Why Global Health Matters. Washington, DC: FamiliesUSA. Archived from the original on 2011-03-08. Retrieved 2008-06-10.
    4. Macfarlane SB, Jacobs M, Kaaya EE (December 2008). "In the name of global health: trends in academic institutions". Journal of Public Health Policy. 29 (4): 383–401. doi:10.1057/jphp.2008.25. PMID   19079297. S2CID   46424271.
    5. Fischer SE, Patil P, Zielinski C, Baxter L, Bonilla-Escobar FJ, Hussain S, et al. (May 2020). "Is it about the 'where' or the 'how'? Comment on Defining global health as public health somewhere else". BMJ Global Health. 5 (5): e002567. doi:10.1136/bmjgh-2020-002567. PMC   7223010 . PMID   32381654.
    6. White F, Nanan DJ (2008). "International and Global Health". In Wallace RB (ed.). Maxcy-Rosenau-Last Public Health and Preventive Medicine (15th ed.). McGraw Hill. pp. 1252–8. ISBN   978-0-07-144198-8.
    7. Roser M, Ortiz-Ospina E, Ritchie H (2013-05-23). "Life Expectancy". Our World in Data.
    8. Conrad PA, Meek LA, Dumit J (May 2013). "Operationalizing a One Health approach to global health challenges". Comparative Immunology, Microbiology and Infectious Diseases. 36 (3): 211–216. doi:10.1016/j.cimid.2013.03.006. PMID   23711930.
    9. Hernando-Amado S, Coque TM, Baquero F, Martínez JL (September 2019). "Defining and combating antibiotic resistance from One Health and Global Health perspectives". Nature Microbiology. 4 (9): 1432–1442. doi:10.1038/s41564-019-0503-9. PMID   31439928. S2CID   201283254.
    10. Sinclair JR (May 2019). "Importance of a One Health approach in advancing global health security and the Sustainable Development Goals". Revue Scientifique et Technique. 38 (1): 145–154. doi:10.20506/rst.38.1.2949. PMID   31564744. S2CID   203608381.
    11. "Millennium Development Goals". United Nations. Retrieved 2013-03-15.
    12. Weatherall DJ, Clegg JB (2001). "Inherited haemoglobin disorders: an increasing global health problem". Bulletin of the World Health Organization. 79 (8): 704–712. PMC   2566499 . PMID   11545326.
    13. Fried LP, Bentley ME, Buekens P, Burke DS, Frenk JJ, Klag MJ, Spencer HC (February 2010). "Global health is public health". Lancet. 375 (9714): 535–537. doi:10.1016/s0140-6736(10)60203-6. PMID   20159277. S2CID   38796542.
    14. Ahern M, Kovats RS, Wilkinson P, Few R, Matthies F (2005). "Global health impacts of floods: epidemiologic evidence". Epidemiologic Reviews. 27 (1): 36–46. doi: 10.1093/epirev/mxi004 . PMID   15958425.
    15. Verano JW, Ubelake DH (1992). Disease and demography in the Americas. Washington: Smithsonian Institution Press. ISBN   978-1-56098-163-3.
    16. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. (January 2012). The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging (Report).
    17. "Global Summits of National Ethics/Bioethics Councils". Berlin. 2016. Archived from the original on 4 April 2019.
    18. Kwete X, Tang K, Chen L, Ren R, Chen Q, Wu Z, et al. (January 2022). "Decolonizing global health: what should be the target of this movement and where does it lead us?". Global Health Research and Policy. 7 (1): 3. doi: 10.1186/s41256-022-00237-3 . PMC   8784247 . PMID   35067229.
    19. Rasheed MA (December 2021). "Navigating the violent process of decolonisation in global health research: a guideline". The Lancet. Global Health. 9 (12): e1640–e1641. doi: 10.1016/S2214-109X(21)00440-X . PMID   34798014. S2CID   244286291.
    20. Affun-Adegbulu C, Adegbulu O (August 2020). "Decolonising Global (Public) Health: from Western universalism to Global pluriversalities". BMJ Global Health. 5 (8): e002947. doi:10.1136/bmjgh-2020-002947. PMC   7443258 . PMID   32819916. S2CID   221220715.
    21. Keshri VR, Bhaumik S (September 2022). "The feudal structure of global health and its implications for decolonisation". BMJ Global Health. 7 (9): e010603. doi:10.1136/bmjgh-2022-010603. PMC   9516156 . PMID   36167407. S2CID   252565623.
    22. World Health Organization. "History of WHO". Archived from the original on 2006-12-07.
    23. Primary Health Care: Report of the International Conference on Primary Health Care (PDF) (Report). Geneva: World Health Organization. 1978. Archived from the original (PDF) on 2017-08-29. Retrieved 2014-05-06.
    24. Kumar S, Kumar N, Vivekadhish S (January–March 2016). "Millennium Development Goals (MDGs) to Sustainable Development Goals (SDGs): Addressing Unfinished Agenda and Strengthening Sustainable Development and Partnership". Indian Journal of Community Medicine. 41 (1): 1–4. doi: 10.4103/0970-0218.170955 . PMC   4746946 . PMID   26917865.
    25. "Resolution adopted by the General Assembly, 55/2" (PDF). United Nations. 18 September 2000.
    26. 1 2 3 "Transforming our world: the 2030 Agenda for Sustainable Development .:. Sustainable Development Knowledge Platform". sustainabledevelopment.un.org. Retrieved 2016-02-26.
    27. 1 2 "Sustainable Development Goals". UNDP. Archived from the original on 2016-03-04. Retrieved 2016-02-26.
    28. Price N (March 23, 2002). "Countries gather to fight poverty". The Sacramento Bee. p. A13. Retrieved 21 November 2022.
    29. Mark Dybul M (Summer 2017). "How HIV, SARS, and Ebola Put Global Health on the Agenda". The Catalyst. George W. Bush Institute.
    30. Hoffman SJ (October 2011). "Ending medical complicity in state-sponsored torture". Lancet. 378 (9802): 1535–1537. doi:10.1016/S0140-6736(11)60816-7. PMID   21944647. S2CID   45829194.
    31. 1 2 Etches V, Frank J, Di Ruggiero E, Manuel D (2006). "Measuring population health: a review of indicators". Annual Review of Public Health. 27: 29–55. doi: 10.1146/annurev.publhealth.27.021405.102141 . PMID   16533108.
    32. Mulholland E, Smith L, Carneiro I, Becher H, Lehmann D (May 2008). "Equity and child-survival strategies". Bulletin of the World Health Organization. 86 (5): 399–407. doi:10.2471/BLT.07.044545. PMC   2647438 . PMID   18545743.
    33. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (May 2006). "Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data". Lancet. 367 (9524): 1747–1757. doi:10.1016/S0140-6736(06)68770-9. PMID   16731270. S2CID   22609505.
    34. Mizgerd JP (February 2006). "Lung infection--a public health priority". PLOS Medicine. 3 (2): e76. doi: 10.1371/journal.pmed.0030076 . PMC   1326257 . PMID   16401173.
    35. "Statistics by Area – Diarrhoeal disease – The challenge". UNICEF. Retrieved 2013-01-12.
    36. Taylor CE, Greenough WB (1989). "Control of diarrheal diseases". Annual Review of Public Health. 10: 221–244. doi: 10.1146/annurev.pu.10.050189.001253 . PMID   2655632.
    37. Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bulletin of the World Health Organization. 78 (10): 1246–1255. PMC   2560623 . PMID   11100619.
    38. "Rotavirus Vaccine Access and Delivery – PATH" (PDF). Rotavirusvaccine.org. 2011-12-07. Archived from the original (PDF) on 2009-12-22. Retrieved 2013-01-12.
    39. Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R (July 2008). "Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico". BMC Infectious Diseases. 8: 103. doi: 10.1186/1471-2334-8-103 . PMC   2527317 . PMID   18664280.
    40. Coovadia HM, Hadingham J (August 2005). "HIV/AIDS: global trends, global funds and delivery bottlenecks". Globalization and Health. 1: 13. doi: 10.1186/1744-8603-1-13 . PMC   1199613 . PMID   16060961.
    41. "HIV/AIDS". World Health Organization. Retrieved 2018-11-01.
    42. "Estimated HIV transmission risk per exposure for specific activities and events". 15 May 2020.
    43. Birn A, Pillay Y, Holtz T (2009). Textbook of International Health (3rd ed.). Oxford University Press. p.  273. ISBN   978-0-19-971985-3.
    44. "Malaria key facts".
    45. "CDC – Malaria – Travelers – Malaria Information and Prophylaxis, by Country". U.S. Centers for Disease Control and Prevention. 2018-01-26. Retrieved 2018-11-01.
    46. Chaves LS, Fry J, Malik A, Geschke A, Sallum MA, Lenzen M (March 2020). "Global consumption and international trade in deforestation-associated commodities could influence malaria risk". Nature Communications. 11 (1): 1258. Bibcode:2020NatCo..11.1258C. doi:10.1038/s41467-020-14954-1. PMC   7062889 . PMID   32152272.
    47. 1 2 3 Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. (December 2022). "Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019". Lancet. 400 (10369): 2221–2248. doi: 10.1016/S0140-6736(22)02185-7 . PMC   9763654 . PMID   36423648.
    48. "Unprecedented progress against neglected tropical diseases, WHO reports". World Health Organization. 2017. Retrieved 2017-05-11.
    49. Horstick O, Tozan Y, Wilder-Smith A (April 2015). "Reviewing dengue: still a neglected tropical disease?". PLOS Neglected Tropical Diseases. 9 (4): e0003632. doi: 10.1371/journal.pntd.0003632 . PMC   4415787 . PMID   25928673.
    50. "CDC – Neglected Tropical Diseases – Diseases". www.cdc.gov. Retrieved 2017-05-11.
    51. Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. (July 2014). "The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases". PLOS Neglected Tropical Diseases. 8 (7): e2865. doi: 10.1371/journal.pntd.0002865 . PMC   4109880 . PMID   25058013.
    52. World Health Organization (2013). Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases; summary (PDF).
    53. London Declaration on Neglected Tropical Diseases (PDF). 2012.
    54. World Health Organization (2017). Integrating Neglected Tropical Diseases into Global Health and Development (PDF).
    55. "Selecting Viruses for the Seasonal Flu Vaccine". Centers for Disease Control and Prevention. 3 November 2022. Retrieved 30 June 2023.
    56. "WHO official: 'Next pandemic may be more severe'". Arab News. 29 December 2020. Retrieved 30 December 2020.
    57. Carrington D (9 March 2021). "Inaction leaves world playing 'Russian roulette' with pandemics, say experts". The Guardian. Retrieved 10 March 2021.
    58. Pagliusi S, Ting CC, Lobos F (March 2017). "Vaccines: Shaping global health". Vaccine. 35 (12): 1579–1585. doi:10.1016/j.vaccine.2017.02.017. PMC   7127343 . PMID   28237501.
    59. Wernli D, Flahault A (2015). "Strengthening research and development for and access to health technologies for neglected diseases and global health threats".
    60. Bloom DE, Cadarette D (2019). "Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response". Frontiers in Immunology. 10: 549. doi: 10.3389/fimmu.2019.00549 . PMC   6447676 . PMID   30984169.
    61. "Improve Maternal Health". UNICEF.
    62. "World Health Report 2005: make every mother and child count". Geneva: World Health Organization. 2005. Archived from the original on April 9, 2005.
    63. "Most Maternal Deaths in Sub-Saharan Africa Could Be Avoided". Science Daily. 2 March 2010. Retrieved 3 March 2011.
    64. 1 2 Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, et al. (February 2008). "What works? Interventions for maternal and child undernutrition and survival". Lancet. 371 (9610): 417–440. doi:10.1016/S0140-6736(07)61693-6. PMID   18206226. S2CID   18345055.
    65. "Progress reports". Countdown to 2015. Archived from the original on 2011-07-25. Retrieved 2011-03-15.
    66. "Challenges". Nutrition. World Health Organization. Archived from the original on March 21, 2006.
    67. Shetty P (2003). "Malnutrition and Undernutrition". Medicine. 31 (4): 18–22. doi:10.1383/medc.31.4.18.27958. ISSN   1357-3039. Malnutrition refers to all deviations from adequate and optimal nutritional status, including energy undernutrition and over-nutrition (obesity is a form of malnutrition). The term 'undernutrition' is used to refer to generally poor nutritional status, but also implies underfeeding
    68. Schaible UE, Kaufmann SH (May 2007). "Malnutrition and infection: complex mechanisms and global impacts". PLOS Medicine. 4 (5): e115. doi: 10.1371/journal.pmed.0040115 . PMC   1858706 . PMID   17472433.
    69. "Vitamin A supplementation". World Health Organization. Archived from the original on 2013-01-25.
    70. Stevens GA, Beal T, Mbuya MN, Luo H, Neufeld LM (November 2022). "Micronutrient deficiencies among preschool-aged children and women of reproductive age worldwide: a pooled analysis of individual-level data from population-representative surveys". The Lancet. Global Health. 10 (11): e1590–e1599. doi: 10.1016/S2214-109X(22)00367-9 . PMID   36240826. S2CID   252857990.
    71. Lynch S, Stoltzfus R, Rawat R (December 2007). "Critical review of strategies to prevent and control iron deficiency in children". Food and Nutrition Bulletin. 28 (4 Suppl): S610–S620. doi: 10.1177/15648265070284S413 . PMID   18297898.
    72. Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, Carter JA (January 2007). "Child development: risk factors for adverse outcomes in developing countries". Lancet. 369 (9556): 145–157. doi:10.1016/S0140-6736(07)60076-2. PMID   17223478. S2CID   11120228.
    73. Lazzerini M (October 2007). "Effect of zinc supplementation on child mortality". Lancet. 370 (9594): 1194–1195. doi:10.1016/S0140-6736(07)61524-4. PMID   17920908. S2CID   33297518.
    74. Fischer Walker CL, Ezzati M, Black RE (May 2009). "Global and regional child mortality and burden of disease attributable to zinc deficiency". European Journal of Clinical Nutrition. 63 (5): 591–597. doi: 10.1038/ejcn.2008.9 . PMID   18270521.
    75. Lazzerini M, Wanzira H (December 2016). "Oral zinc for treating diarrhoea in children". The Cochrane Database of Systematic Reviews. 12 (12): CD005436. doi:10.1002/14651858.CD005436.pub5. PMC   5450879 . PMID   27996088.
    76. "WHO: Global Status Report on Noncommunicable Diseases 2010". 2011. Archived from the original on April 30, 2011.
    77. Menhas R, Dai J, Ashraf MA, M Noman S, Khurshid S, Mahmood S, et al. (2021-06-03). "Physical Inactivity, Non-Communicable Diseases and National Fitness Plan of China for Physical Activity". Risk Management and Healthcare Policy. 14: 2319–2331. doi: 10.2147/RMHP.S258660 . PMC   8184286 . PMID   34113188.
    78. "Comprehensive health study in India finds rise of non-communicable diseases". 2017-11-13. Archived from the original on 2023-02-09. Retrieved 2018-11-01.
    79. Amara AH, Aljunid SM (April 2014). "Noncommunicable diseases among urban refugees and asylum-seekers in developing countries: a neglected health care need". Globalization and Health. 10: 24. doi: 10.1186/1744-8603-10-24 . PMC   3978000 . PMID   24708876.
    80. "Press Conference on General Assembly Decision to Convene Summit in September 2011 on Non-Communicable Diseases". New York: United Nations. 13 May 2010.
    81. 1 2 Hossain P, Kawar B, El Nahas M (January 2007). "Obesity and diabetes in the developing world--a growing challenge". The New England Journal of Medicine. 356 (3): 213–215. doi: 10.1056/NEJMp068177 . PMID   17229948.
    82. World report on hearing. World Health Organization. Geneva. 2021. ISBN   978-92-4-002048-1. OCLC   1295473345.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
    83. "Lifestyle disease". MedicineNet. Retrieved 2016-05-12.
    84. Mathur P, Mascarenhas L (2019). "Lifestyle diseases: Keeping fit for a better tomorrow". The Indian Journal of Medical Research. 149 (Suppl 1): S129–S135. doi: 10.4103/0971-5916.251669 . PMC   6515727 . PMID   31070189.
    85. "Lifestyle diseases 'cost economy'". Cape Argus. Cape Town. 13 September 2011. ProQuest   889325276.
    86. Engelen L, Gale J, Chau JY, Hardy LL, Mackey M, Johnson N, Shirley D, Bauman A (2017). "Who is at risk of chronic disease? Associations between risk profiles of physical activity, sitting and cardio-metabolic disease in Australian adults". Australian and New Zealand Journal of Public Health. 41 (2): 178–183. doi: 10.1111/1753-6405.12627 . PMID   27960249. S2CID   34368321. ProQuest   2290216359.
    87. Bitar AR (January 2018). Diet and the Disease of Civilization. Rutgers University Press. ISBN   978-0-8135-8964-0.
    88. Pollan M (2008). In Defense of Food: An Eater's Manifesto . Penguin Press HC, The. ISBN   978-1-59420-145-5.
    89. "Commercial determinants of health". www.who.int. Retrieved 5 December 2022.
    90. WHO (2005). "Cancer". Archived from the original on May 18, 2020.
    91. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" (PDF). Lancet. 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl: 10536/DRO/DU:30050819 . PMID   23245604. S2CID   1541253. Archived from the original (PDF) on February 11, 2020.
    92. "The top 10 causes of death". www.who.int.
    93. Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. (December 2022). "Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019". Lancet. 400 (10369): 2221–2248. doi: 10.1016/S0140-6736(22)02185-7 . PMC   9763654 . PMID   36423648.
    94. "Cause of Death". UC Atlas of Global Inequality. University of California, Santa Cruz. 18 February 2004. Archived from the original on 18 June 2014. Retrieved 2014-06-09.
    95. "Violence Against Women Fact Sheet". The United Nations Population Fund. 2005. Archived from the original on 2012-09-08. Retrieved 2012-09-29.
    96. Ellsberg M, and Heise L. Researching Violence Against Women: A Practical Guide for Researchers and Activists. Washington DC, United States: World Health Organization, PATH; 2005. Accessed September 19, 2012.
    97. Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. WHO. 2013. hdl:10665/85239. ISBN   978-9-24-156462-5.
    98. Addressing violence against women and achieving the Millennium Development Goals. World Health Organization (Report). Geneva, Switzerland. September 2005.
    99. "Violence against women: Intimate partner and sexual violence against women fact sheet". World Health Organization. 2011.
    100. Cockerham WC, Quah SR, eds. (2017). International Encyclopedia of Public Health (Second ed.). Elsevier/AP. ISBN   978-0-12-803708-9.
    101. WHO. "The World Health Assembly endorses the global plan of action on violence against women and girls, and also against children". WHO.int. Retrieved 1 December 2019.
    102. Mahler H. Address by Dr. H. Mahler, Director General of the World Health Organization, in presenting his report for 1986 and 1987. Forty-first World Health Assembly: world health-2000 and beyond. (Report). JSTOR   41989284.
    103. 1 2 3 4 5 6 Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. (August 2015). "Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development". Lancet. 386 (9993): 569–624. doi: 10.1016/S0140-6736(15)60160-X . PMID   25924834. S2CID   2048403.
    104. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA (July 2008). "An estimation of the global volume of surgery: a modelling strategy based on available data". Lancet. 372 (9633): 139–144. doi:10.1016/S0140-6736(08)60878-8. PMID   18582931. S2CID   17918156.
    105. 1 2 McQueen KA, Ozgediz D, Riviello R, Hsia RY, Jayaraman S, Sullivan SR, Meara JG (June 2010). "Essential surgery: Integral to the right to health". Health and Human Rights. 12 (1): 137–152. PMID   20930260.
    106. Shrime MG, Bickler SW, Alkire BC, Mock C (April 2015). "Global burden of surgical disease: an estimation from the provider perspective". The Lancet. Global Health. 3 (Suppl 2): S8–S9. doi: 10.1016/S2214-109X(14)70384-5 . PMID   25926322.
    107. Bath M, Bashford T, Fitzgerald JE (2019). "What is 'global surgery'? Defining the multidisciplinary interface between surgery, anaesthesia and public health". BMJ Global Health. 4 (5): e001808. doi:10.1136/bmjgh-2019-001808. PMC   6830053 . PMID   31749997.
    108. Farmer PE, Kim JY (April 2008). "Surgery and global health: a view from beyond the OR". World Journal of Surgery. 32 (4): 533–536. doi:10.1007/s00268-008-9525-9. PMC   2267857 . PMID   18311574.
    109. Dare AJ, Grimes CE, Gillies R, Greenberg SL, Hagander L, Meara JG, Leather AJ (December 2014). "Global surgery: defining an emerging global health field". Lancet. 384 (9961): 2245–2247. doi:10.1016/S0140-6736(14)60237-3. PMID   24853601. S2CID   37349469.
    110. O'Neill KM, Greenberg SL, Cherian M, Gillies RD, Daniels KM, Roy N, et al. (November 2016). "Bellwether Procedures for Monitoring and Planning Essential Surgical Care in Low- and Middle-Income Countries: Caesarean Delivery, Laparotomy, and Treatment of Open Fractures". World Journal of Surgery. Springer Science and Business Media LLC. 40 (11): 2611–2619. doi:10.1007/s00268-016-3614-y. PMID   27351714. S2CID   12830913.
    111. Chao TE, Sharma K, Mandigo M, Hagander L, Resch SC, Weiser TG, Meara JG (June 2014). "Cost-effectiveness of surgery and its policy implications for global health: a systematic review and analysis". The Lancet. Global Health. 2 (6): e334–e345. doi: 10.1016/S2214-109X(14)70213-X . PMID   25103302.
    112. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ (July 2003). "Household catastrophic health expenditure: a multicountry analysis". Lancet. 362 (9378): 111–117. doi:10.1016/S0140-6736(03)13861-5. PMID   12867110. S2CID   2052830.
    113. Price R, Makasa E, Hollands M (September 2015). "World Health Assembly Resolution WHA68.15: "Strengthening Emergency and Essential Surgical Care and Anesthesia as a Component of Universal Health Coverage"—Addressing the Public Health Gaps Arising from Lack of Safe, Affordable and Accessible Surgical and Anesthetic Services". World Journal of Surgery. 39 (9): 2115–2125. doi:10.1007/s00268-015-3153-y. PMID   26239773. S2CID   13027859.
    114. Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN (2015-03-24). Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN (eds.). Disease Control Priorities. Vol. 1 Essential Surgery (Third ed.). doi:10.1596/978-1-4648-0346-8. hdl:10986/21568. ISBN   978-1-4648-0367-3. PMID   26740991.
    115. 1 2 Truché P, Shoman H, Reddy CL, Jumbam DT, Ashby J, Mazhiqi A, et al. (January 2020). "Globalization of national surgical, obstetric and anesthesia plans: the critical link between health policy and action in global surgery". Globalization and Health. 16 (1): 1. doi: 10.1186/s12992-019-0531-5 . PMC   6941290 . PMID   31898532.
    116. "NIHR Global Health Research Unit on Global Surgery". The NIHR Global Health Research Unit on Global Surgery.
    117. "NIHR Global Health Research Unit on Global Surgery - University of Birmingham". The NIHR Global Health Research Unit on Global Surgery.
    118. "About GlobalSurg". GlobalSurg. Retrieved January 28, 2023.
    119. "CovidSurg". GlobalSurg. April 30, 2005. Retrieved January 28, 2023.
    120. NIHR Global Research Health Unit on Global Surgery (October 25, 2021). "Reducing surgical site infections in low-income and middle-income countries (FALCON): a pragmatic, multicentre, stratified, randomised controlled trial". Lancet. 398 (10312): 1687–1699. doi:10.1016/S0140-6736(21)01548-8. PMC   8586736 . PMID   34710362.
    121. NIHR Global Research Health Unit on Global Surgery (October 31, 2022). "Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven low-income and middle-income countries". Lancet. 400 (10365): 1767–76. doi:10.1016/S0140-6736(22)01884-0. PMID   36328045. S2CID   253242381.
    122. GlobalSurg Collaborative (February 13, 2018). "Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study". The Lancet Infectious Diseases. 18 (5): 516–525. doi:10.1016/S1473-3099(18)30101-4. PMC   5910057 . PMID   29452941.
    123. COVIDSurg Collaborative (May 29, 2020). "Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study". Lancet. 396 (10243): 27–38. doi:10.1016/S0140-6736(20)31182-X. PMC   7259900 . PMID   32479829.
    124. GlobalSurg Collaborative (4 May 2016). "Mortality of emergency abdominal surgery in high-, middle- and low-income countries". British Journal of Surgery. 103 (8): 971–988. doi:10.1002/bjs.10151. hdl: 2027.42/146346 . PMID   27145169. S2CID   217871463.
    125. Global PaedSurg Research Collaboration (July 13, 2021). "Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study". Lancet. 398 (10297): 325–339. doi:10.1016/S0140-6736(18)30001-1. PMC   8314066 . PMID   34270932.
    126. "La géographie détermine la survie des bébés nés avec des malformations congénitales à travers le monde". FrenchPlanete. 26 July 2021.
    127. "Landmark Trial Concludes to address the problem of Post-operative Death in Africa". SunsineSlate. August 26, 2021.
    128. Biccard BM, Madiba TE, Kluyts HL, Munlemvo DM, Madzimbamuto FD, Basenero A, et al. (African Surgical Outcomes Study (ASOS) investigators.) (April 2018). "Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study". Lancet. 391 (10130): 1589–1598. doi:10.1016/S0140-6736(18)30001-1. PMID   29306587. S2CID   4666606.
    129. "Geography determined Survival for Newborns with Congenital Birth Defects". MaxiNews. July 26, 2021.
    130. Hariri P, Clarke R, Bragg F, Chen Y, Guo Y, Yang L, et al. (January 2022). "Frequency and types of clusters of major chronic diseases in 0.5 million adults in urban and rural China". Journal of Multimorbidity and Comorbidity. 12: 26335565221098327. doi:10.1177/26335565221098327. PMC   9125108 . PMID   35615751.
    131. The Lancet (April 2018). "Making more of multimorbidity: an emerging priority". Lancet. 391 (10131): 1637. doi: 10.1016/S0140-6736(18)30941-3 . PMID   29726322.
    132. Pearson-Stuttard J, Ezzati M, Gregg EW (December 2019). "Multimorbidity-a defining challenge for health systems". The Lancet. Public Health. 4 (12): e599–e600. doi:10.1016/S2468-2667(19)30222-1. hdl: 10044/1/75127 . PMID   31812234. S2CID   208955266.
    133. Kuan V, Denaxas S, Patalay P, Nitsch D, Mathur R, Gonzalez-Izquierdo A, et al. (January 2023). "Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study". The Lancet. Digital Health. 5 (1): e16–e27. doi: 10.1016/S2589-7500(22)00187-X . PMID   36460578. S2CID   254129048.
    134. Garmany A, Yamada S, Terzic A (September 2021). "Longevity leap: mind the healthspan gap". npj Regenerative Medicine. 6 (1): 57. doi:10.1038/s41536-021-00169-5. PMC   8460831 . PMID   34556664.
    135. Farrelly C (November 2022). "Aging, Equality and the Human Healthspan". HEC Forum: 1–19. doi:10.1007/s10730-022-09499-3. PMC   9644010 . PMID   36348214.
    136. 1 2 "Humans could face reproductive crisis as sperm count declines, study finds". The Guardian. 15 November 2022. Retrieved 27 November 2022.
    137. Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Jolles M, et al. (March 2023). "Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries". Human Reproduction Update. 29 (2): 157–176. doi: 10.1093/humupd/dmac035 . PMID   36377604.
    138. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, et al. (April 2006). "Advancement of global health: key messages from the Disease Control Priorities Project". Lancet. 367 (9517): 1193–1208. doi:10.1016/S0140-6736(06)68440-7. PMID   16616562. S2CID   1567552.
    139. Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW (2005). "Can the world afford to save the lives of 6 million children each year?". Lancet. 365 (9478): 2193–2200. doi:10.1016/S0140-6736(05)66777-3. PMID   15978927. S2CID   46067330.
    140. "Interventions in Health". Global Health Council. Archived from the original on 2011-01-06.
    141. Farmer P (July 2001). "The major infectious diseases in the world--to treat or not to treat?". The New England Journal of Medicine. 345 (3): 208–210. doi:10.1056/NEJM200107193450310. PMID   11463018.
    142. Anson A, Ramay B, de Esparza AR, Bero L (July 2012). "Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala". Globalization and Health. 8: 22. doi: 10.1186/1744-8603-8-22 . PMC   3503802 . PMID   22747646.
    143. Kiani A, Qadeer A, Mirza Z, Khanum A, Tisocki K, Mustafa T. "Prices, availability and affordability of medicines in Pakistan" (PDF). Geneva: Health Action International. 2006. Archived from the original (PDF) on 14 December 2010. Retrieved 7 April 2014.
    144. Garrett L (2007). "The Challenge of Global Health". Foreign Affairs (January/February 2007).
    145. "The world health report 2006: working together for health". Geneva: World Health Organization. Archived from the original on December 2, 2006.
    146. Haakenstad A, Irvine CM, Knight M, Bintz C, Aravkin AY, Zheng P, et al. (June 2022). "Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019". Lancet. 399 (10341): 2129–2154. doi:10.1016/S0140-6736(22)00532-3. PMC   9168805 . PMID   35617980.
    147. Kilmarx PH, Maitin T, Adam T, Akuffo H, Aslanyan G, Cheetham M, et al. (August 2020). "A Mechanism for Reviewing Investments in Health Research Capacity Strengthening in Low- and Middle-Income Countries". Annals of Global Health. 86 (1): 92. doi: 10.5334/aogh.2941 . PMC   7413164 . PMID   32832386.
    148. Cissé, G., R. McLeman, H. Adams, P. Aldunce, K. Bowen, D. Campbell-Lendrum, S. Clayton, K.L. Ebi, J. Hess, C. Huang, Q. Liu, G. McGregor, J. Semenza, and M.C. Tirado, 2022: Chapter 7: Health, Wellbeing, and the Changing Structure of Communities. In: Climate Change 2022: Impacts, Adaptation and Vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change [H.-O. Pörtner, D.C. Roberts, M. Tignor, E.S. Poloczanska, K. Mintenbeck, A. Alegría, M. Craig, S. Langsdorf, S. Löschke, V. Möller, A. Okem, B. Rama (eds.)]. Cambridge University Press, Cambridge, UK and New York, NY, USA, pp. 1041–1170, doi:10.1017/9781009325844.009.
    149. Marina Romanello, Claudia Di Napoli, Paul Drummond, Carole Green, Harry Kennard, Pete Lampard, Daniel Scamman, Nigel Arnell, Sonja Ayeb-Karlsson, Lea Berrang Ford, Kristine Belesova, Kathryn Bowen, Wenjia Cai, Max Callaghan, Diarmid Campbell-Lendrum, Jonathan Chambers, Kim R van Daalen, Carole Dalin, Niheer Dasandi, Shouro Dasgupta, Michael Davies, Paula Dominguez-Salas, Robert Dubrow, Kristie L Ebi, Matthew Eckelman, Paul Ekins, Luis E Escobar, Lucien Georgeson, Hilary Graham, Samuel H Gunther, Ian Hamilton, Yun Hang, Risto Hänninen, Stella Hartinger, Kehan He, Jeremy J Hess, Shih-Che Hsu, Slava Jankin, Louis Jamart et al. (2022) The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels, The Lancet, Vol 400 November 5, DOI: 10.1016/ S0140-6736(22)01540-9
    150. 1 2 3 4 5 Romanello M, McGushin A, Di Napoli C, Drummond P, Hughes N, Jamart L, Kennard H, Lampard P, Solano Rodriguez B, Arnell N, Ayeb-Karlsson S, Belesova K, Cai W, Campbell-Lendrum D, Capstick S, Chambers J, Chu L, Ciampi L, Dalin C, Dasandi N, Dasgupta S, Davies M, Dominguez-Salas P, Dubrow R, Ebi KL, Eckelman M, Ekins P, Escobar LE, Georgeson L, Grace D, Graham H, Gunther SH, Hartinger S, He K, Heaviside C, Hess J, Hsu S, Jankin S, Jimenez MP, Kelman I, et al. (October 2021). "The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future" (PDF). The Lancet. 398 (10311): 1619–1662. doi:10.1016/S0140-6736(21)01787-6. hdl: 10278/3746207 . PMID   34687662. S2CID   239046862.
    151. Levy K, Smith SM, Carlton EJ (2018). "Climate Change Impacts on Waterborne Diseases: Moving Toward Designing Interventions". Current Environmental Health Reports. 5 (2): 272–282. doi:10.1007/s40572-018-0199-7. ISSN   2196-5412. PMC   6119235 . PMID   29721700.
    152. Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, Takahashi S, Tatem AJ, Wagner CE, Wang L, Wesolowski A, Metcalf CJ (April 2022). "Infectious disease in an era of global change". Nature Reviews Microbiology. 20 (4): 193–205. doi:10.1038/s41579-021-00639-z. ISSN   1740-1534. PMC   8513385 . PMID   34646006.
    153. Wilson ME (2010). "Geography of infectious diseases". Infectious Diseases: 1055–1064. doi:10.1016/B978-0-323-04579-7.00101-5. ISBN   9780323045797. PMC   7152081 .
    154. 1 2 3 Watts N, Amann M, Arnell N, Ayeb-Karlsson S, Belesova K, Boykoff M, Byass P, Cai W, Campbell-Lendrum D, Capstick S, Chambers J (16 November 2019). "The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate" (PDF). The Lancet. 394 (10211): 1836–1878. doi:10.1016/S0140-6736(19)32596-6. PMID   31733928. S2CID   207976337.
    155. 1 2 3 Watts N, Adger WN, Agnolucci P, Blackstock J, Byass P, Cai W, Chaytor S, Colbourn T, Collins M, Cooper A, Cox PM (2015). "Health and climate change: policy responses to protect public health". The Lancet. 386 (10006): 1861–1914. doi:10.1016/S0140-6736(15)60854-6. hdl: 10871/17695 . PMID   26111439. S2CID   205979317.
    156. Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, Friel S, Groce N, Johnson A, Kett M, Lee M (2009). "Managing the health effects of climate change". The Lancet. 373 (9676): 1693–1733. doi:10.1016/S0140-6736(09)60935-1. PMID   19447250. S2CID   205954939.
    157. "WHO calls for urgent action to protect health from climate change – Sign the call". www.who.int. World Health Organization. 2015. Archived from the original on October 8, 2015. Retrieved 2020-04-19.
    158. Katharine Murphy (2 September 2019). "Australian Medical Association declares climate change a health emergency". The Guardian . Retrieved 19 April 2020.
    159. Kotcher J, Maibach E, Miller J, Campbell E, Alqodmani L, Maiero M, Wyns A (May 2021). "Views of health professionals on climate change and health: a multinational survey study". The Lancet Planetary Health. 5 (5): e316–e323. doi:10.1016/S2542-5196(21)00053-X. PMC   8099728 . PMID   33838130.
    160. Maibach EW, Nisbet M, Baldwin P, Akerlof K, Diao G (December 2010). "Reframing climate change as a public health issue: an exploratory study of public reactions". BMC Public Health. 10 (1): 299. doi: 10.1186/1471-2458-10-299 . PMC   2898822 . PMID   20515503.
    161. Dasandi N, Graham H, Hudson D, Jankin S, vanHeerde-Hudson J, Watts N (20 October 2022). "Positive, global, and health or environment framing bolsters public support for climate policies". Communications Earth & Environment. 3 (1): 239. Bibcode:2022ComEE...3..239D. doi: 10.1038/s43247-022-00571-x . S2CID   253041860.
    162. "Global health at mercy of fossil fuel addiction, warn scientists". The Guardian. 25 October 2022. Retrieved 17 November 2022.
    163. Romanello M, Di Napoli C, Drummond P, Green C, Kennard H, Lampard P, et al. (November 2022). "The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels". Lancet. 400 (10363): 1619–1654. doi: 10.1016/S0140-6736(22)01540-9 . PMID   36306815. S2CID   253148997.
    164. 1 2 D'Amato G, Pawankar R, Vitale C, Lanza M, Molino A, Stanziola A, Sanduzzi A, Vatrella A, D'Amato M. Climate Change and Air Pollution: Effects on Respiratory Allergy. Allergy Asthma Immunol Res. 2016 Sep;8(5):391-5. doi: 10.4168/aair.2016.8.5.391. PMID 27334776; PMCID: PMC4921692.
    165. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol Archived 26 June 2011 at the Wayback Machine , Jan Hudzicki, ASM
    166. 1 2 "Antimicrobial resistance Fact sheet N°194". who.int. April 2014. Archived from the original on 10 March 2015. Retrieved 7 March 2015.
    167. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. (March 2012). "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance". Clinical Microbiology and Infection. 18 (3): 268–281. doi: 10.1111/j.1469-0691.2011.03570.x . PMID   21793988.
    168. 1 2 Tanwar J, Das S, Fatima Z, Hameed S (2014). "Multidrug resistance: an emerging crisis". Interdisciplinary Perspectives on Infectious Diseases. 2014: 541340. doi: 10.1155/2014/541340 . PMC   4124702 . PMID   25140175.
    169. 1 2 Saha M, Sarkar A (December 2021). "Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century". Journal of Xenobiotics. 11 (4): 197–214. doi: 10.3390/jox11040013 . PMC   8708150 . PMID   34940513.
    170. "General Background: About Antibiotic Resistance". www.tufts.edu. Archived from the original on 23 October 2015. Retrieved 30 October 2015.
    171. Dabour R, Meirson T, Samson AO (December 2016). "Global antibiotic resistance is mostly periodic". Journal of Global Antimicrobial Resistance. 7: 132–134. doi:10.1016/j.jgar.2016.09.003. PMID   27788414.
    172. 1 2 Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. (September 2022). "Tackling the emerging threat of antifungal resistance to human health". Nature Reviews. Microbiology. 20 (9): 557–571. doi:10.1038/s41579-022-00720-1. PMC   8962932 . PMID   35352028.
    173. Ikuta KS, et al. (December 2022). "Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019". Lancet. 400 (10369): 2221–2248. doi:10.1016/S0140-6736(22)02185-7. PMC   9763654 . PMID   36423648.
    174. 1 2 Murray CJ, et al. (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. PMC   8841637 . PMID   35065702.
    175. 1 2 "About Antimicrobial Resistance". www.cdc.gov. 10 September 2018. Archived from the original on 1 October 2017. Retrieved 30 October 2015.
    176. 1 2 Swedish work on containment of antibiotic resistance – Tools, methods and experiences (PDF). Stockholm: Public Health Agency of Sweden. 2014. pp. 16–17, 121–128. ISBN   978-91-7603-011-0. Archived (PDF) from the original on 23 July 2015. Retrieved 23 July 2015.
    177. "Duration of antibiotic therapy and resistance". NPS Medicinewise. National Prescribing Service Limited trading, Australia. 13 June 2013. Archived from the original on 23 July 2015. Retrieved 22 July 2015.
    178. Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R, et al. (December 2017). "Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections". JAMA. 318 (23): 2325–2336. doi:10.1001/jama.2017.18715. PMC   5820700 . PMID   29260224.
    179. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva: World Health Organization (WHO). 2022. ISBN   978-92-4-006238-2. Archived from the original on 13 August 2023. Retrieved 28 March 2023.
    180. "CDC Features – Mission Critical: Preventing Antibiotic Resistance". www.cdc.gov. 4 April 2018. Archived from the original on 8 November 2017. Retrieved 22 July 2015.
    181. "Impacts of Pharmaceutical Pollution on Communities and Environment in India" (PDF). Nordea. February 2016. Archived (PDF) from the original on 20 May 2017. Retrieved 1 May 2018.
    182. Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI (July 2011). "Selection of resistant bacteria at very low antibiotic concentrations". PLOS Pathogens. 7 (7): e1002158. doi: 10.1371/journal.ppat.1002158 . PMC   3141051 . PMID   21811410.
    183. Cassir N, Rolain JM, Brouqui P (2014). "A new strategy to fight antimicrobial resistance: the revival of old antibiotics". Frontiers in Microbiology. 5: 551. doi: 10.3389/fmicb.2014.00551 . PMC   4202707 . PMID   25368610.
    184. Sample I (26 March 2018). "Calls to rein in antibiotic use after study shows 65% increase worldwide". The Guardian. Archived from the original on 8 April 2018. Retrieved 28 March 2018.
    185. Dramé O, Leclair D, Parmley EJ, Deckert A, Ouattara B, Daignault D, Ravel A (August 2020). "Antimicrobial Resistance of Campylobacter in Broiler Chicken Along the Food Chain in Canada". Foodborne Pathogens and Disease. 17 (8): 512–520. doi:10.1089/fpd.2019.2752. PMC   7415884 . PMID   32130036.
    186. WHO (April 2014). "Antimicrobial resistance: global report on surveillance 2014". WHO. Archived from the original on 15 May 2015. Retrieved 9 May 2015.
    187. O'Neill J (May 2016). "Tackling drug-resistant infections globally: final report and recommendations" (PDF). amr-review.org/. Archived (PDF) from the original on 14 November 2017. Retrieved 10 November 2017.
    188. Dadgostar P (2019-12-20). "Antimicrobial Resistance: Implications and Costs". Infection and Drug Resistance. 12: 3903–3910. doi: 10.2147/IDR.S234610 . PMC   6929930 . PMID   31908502.
    189. "The biggest antibiotic-resistant threats in the U.S." Centers for Disease Control and Prevention. 6 November 2019. Archived from the original on 6 November 2019. Retrieved 15 November 2019.
    190. Chanel S, Doherty B (2020-09-10). "'Superbugs' a far greater risk than Covid in Pacific, scientist warns". The Guardian. ISSN   0261-3077. Archived from the original on 5 December 2022. Retrieved 2020-09-14.
    191. Samuel S (2019-05-07). "Our antibiotics are becoming useless". Vox. Archived from the original on 11 May 2021. Retrieved 2021-01-28.
    192. Hoffman SJ, Outterson K, Røttingen JA, Cars O, Clift C, Rizvi Z, et al. (February 2015). "An international legal framework to address antimicrobial resistance". Bulletin of the World Health Organization. 93 (2): 66. doi:10.2471/BLT.15.152710. PMC   4339972 . PMID   25883395.
    193. Kwon JH, Powderly WG (July 30, 2021). "The post-antibiotic era is here". Science. American Association for the Advancement of Science. 373 (6554): 471. Bibcode:2021Sci...373..471K. doi: 10.1126/science.abl5997 . PMID   34326211. S2CID   236501941.
    194. Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, et al. (March 2021). "Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance". Trans R Soc Trop Med Hyg. 115 (10): 1122–1129. doi:10.1093/trstmh/trab048. PMC   8083707 . PMID   33772597.
    195. "COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022". CDC. 2022. doi: 10.15620/cdc:117915 . S2CID   249320411. Archived from the original on 22 March 2023. Retrieved 2023-03-28.
    196. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. (February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. PMC   8841637 . PMID   35065702.
    197. Clinton C, Sridhar D (July 2017). "Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance" (PDF). Lancet. 390 (10091): 324–332. doi:10.1016/S0140-6736(16)32402-3. hdl: 20.500.11820/6efaf7e1-836c-42a6-a582-c7e5c7b458fd . PMID   28139255. S2CID   23911963.
    198. Michaud J, Moss K, Licina D, Waldman R, Kamradt-Scott A, Bartee M, et al. (January 2019). "Militaries and global health: peace, conflict, and disaster response". Lancet. 393 (10168): 276–286. doi: 10.1016/S0140-6736(18)32838-1 . PMID   30663597. S2CID   58624715.
    199. Riley K (2018-03-21). "U.S. at a critical juncture with Global Health Security Agenda". Homeland Preparedness News. Retrieved 2018-03-23.
    200. "Global Health Security Agenda: Action Packages". 23 July 2021 via U.S. Centers for Disease Control and Prevention (CDC).
    201. 1 2 McPhee E, Gronvall GK, Sell TK (May 2019). "Analysis of sectoral participation in the development of Joint External Evaluations". BMC Public Health. 19 (1): 631. doi: 10.1186/s12889-019-6978-8 . PMC   6533773 . PMID   31122234.
    202. "Global Health Security Agenda: Action Packages". CDC. 2016. Retrieved 18 November 2019.
    203. Wolicki SB, Nuzzo JB, Blazes DL, Pitts DL, Iskander JK, Tappero JW (2016). "Public Health Surveillance: At the Core of the Global Health Security Agenda". Health Security. 14 (3): 185–8. doi:10.1089/hs.2016.0002. PMC   6937158 . PMID   27314658.

    Further reading